Both in Pharmaceuticals
Palvella Therapeutics vs Immunome
Over the past year PVLA returned +86.4% and IMNM returned +14.0%; their daily moves had a correlation of 0.31.
PVLA +86.4% IMNM +14.0%Growth of $1, one year, split-adjusted
| Metric | PVLA | IMNM |
|---|---|---|
| Price | $146.15 | $18.21 |
| Market cap | $2.11B | $2.15B |
| Today | −3.58% | −0.44% |
| 1 month | +10.1% | −12.8% |
| 6 months | +15.2% | −19.9% |
| Year to date | +39.6% | −15.2% |
| 1 year | +94.4% | +15.5% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $250.6M | $520.0M |
| Dividend yield | — | — |
| Volatility (60d) | 47.0% | 55.6% |
| Short % of float | 21.7% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).